PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
PLTK vs. EBS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between PLTK and EBS is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

PLTK vs. EBS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Playtika Holding Corp. (PLTK) and Emergent BioSolutions Inc. (EBS). The values are adjusted to include any dividend payments, if applicable.

-95.00%-90.00%-85.00%-80.00%-75.00%-70.00%OctoberNovemberDecember2025FebruaryMarch
-84.78%
-94.82%
PLTK
EBS

Key characteristics

Sharpe Ratio

PLTK:

-0.89

EBS:

0.69

Sortino Ratio

PLTK:

-1.16

EBS:

2.01

Omega Ratio

PLTK:

0.84

EBS:

1.27

Calmar Ratio

PLTK:

-0.39

EBS:

0.98

Martin Ratio

PLTK:

-2.10

EBS:

2.92

Ulcer Index

PLTK:

16.07%

EBS:

33.09%

Daily Std Dev

PLTK:

37.94%

EBS:

140.14%

Max Drawdown

PLTK:

-85.96%

EBS:

-98.89%

Current Drawdown

PLTK:

-85.96%

EBS:

-95.92%

Fundamentals

Market Cap

PLTK:

$1.74B

EBS:

$540.22M

EPS

PLTK:

$0.44

EBS:

-$11.22

Total Revenue (TTM)

PLTK:

$2.55B

EBS:

$1.04B

Gross Profit (TTM)

PLTK:

$1.86B

EBS:

$320.40M

EBITDA (TTM)

PLTK:

$603.60M

EBS:

$38.70M

Returns By Period

In the year-to-date period, PLTK achieves a -33.29% return, which is significantly higher than EBS's -42.36% return.


PLTK

YTD

-33.29%

1M

-37.26%

6M

-36.57%

1Y

-33.51%

5Y*

N/A

10Y*

N/A

EBS

YTD

-42.36%

1M

-43.02%

6M

-27.79%

1Y

145.98%

5Y*

-39.74%

10Y*

-14.52%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

PLTK vs. EBS — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PLTK
The Risk-Adjusted Performance Rank of PLTK is 1111
Overall Rank
The Sharpe Ratio Rank of PLTK is 77
Sharpe Ratio Rank
The Sortino Ratio Rank of PLTK is 1010
Sortino Ratio Rank
The Omega Ratio Rank of PLTK is 1010
Omega Ratio Rank
The Calmar Ratio Rank of PLTK is 2727
Calmar Ratio Rank
The Martin Ratio Rank of PLTK is 11
Martin Ratio Rank

EBS
The Risk-Adjusted Performance Rank of EBS is 8181
Overall Rank
The Sharpe Ratio Rank of EBS is 7676
Sharpe Ratio Rank
The Sortino Ratio Rank of EBS is 8484
Sortino Ratio Rank
The Omega Ratio Rank of EBS is 8484
Omega Ratio Rank
The Calmar Ratio Rank of EBS is 8383
Calmar Ratio Rank
The Martin Ratio Rank of EBS is 7777
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

PLTK vs. EBS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Playtika Holding Corp. (PLTK) and Emergent BioSolutions Inc. (EBS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for PLTK, currently valued at -0.89, compared to the broader market-3.00-2.00-1.000.001.002.003.00-0.890.69
The chart of Sortino ratio for PLTK, currently valued at -1.16, compared to the broader market-4.00-2.000.002.004.00-1.162.01
The chart of Omega ratio for PLTK, currently valued at 0.84, compared to the broader market0.501.001.502.000.841.27
The chart of Calmar ratio for PLTK, currently valued at -0.39, compared to the broader market0.001.002.003.004.005.00-0.390.98
The chart of Martin ratio for PLTK, currently valued at -2.10, compared to the broader market-10.000.0010.0020.00-2.102.92
PLTK
EBS

The current PLTK Sharpe Ratio is -0.89, which is lower than the EBS Sharpe Ratio of 0.69. The chart below compares the historical Sharpe Ratios of PLTK and EBS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00OctoberNovemberDecember2025FebruaryMarch
-0.89
0.69
PLTK
EBS

Dividends

PLTK vs. EBS - Dividend Comparison

PLTK's dividend yield for the trailing twelve months is around 6.48%, while EBS has not paid dividends to shareholders.


TTM202420232022202120202019201820172016
PLTK
Playtika Holding Corp.
6.48%4.32%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBS
Emergent BioSolutions Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%5.65%

Drawdowns

PLTK vs. EBS - Drawdown Comparison

The maximum PLTK drawdown since its inception was -85.96%, smaller than the maximum EBS drawdown of -98.89%. Use the drawdown chart below to compare losses from any high point for PLTK and EBS. For additional features, visit the drawdowns tool.


-95.00%-90.00%-85.00%-80.00%-75.00%OctoberNovemberDecember2025FebruaryMarch
-85.96%
-95.60%
PLTK
EBS

Volatility

PLTK vs. EBS - Volatility Comparison

The current volatility for Playtika Holding Corp. (PLTK) is 20.75%, while Emergent BioSolutions Inc. (EBS) has a volatility of 26.79%. This indicates that PLTK experiences smaller price fluctuations and is considered to be less risky than EBS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%OctoberNovemberDecember2025FebruaryMarch
20.75%
26.79%
PLTK
EBS

Financials

PLTK vs. EBS - Financials Comparison

This section allows you to compare key financial metrics between Playtika Holding Corp. and Emergent BioSolutions Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab